featured
Clinical Validity of [18F]-FES PET to Assess ER Status in Newly Diagnosed Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer
J. Clin. Oncol 2022 May 18;[EPub Ahead of Print], JJL van Geel, J Boers, SG Elias, AWJM Glaudemans, EFJ de Vries, GAP Hospers, M van Kruchten, EJM Kuip, A Jager, WC Menke-van der Houven van Oordt, B van der Vegt, EGE de Vries, CP SchröderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.